A Xeljanz lawsuit is a way for individuals to hold the drug company responsible for the risks associated with the drug. Pfizer was responsible for the development and marketing of Xeljanz and had a duty to warn medical professionals and the public about its risks. However, they failed to do so, and instead provided misleading and false information to patients and doctors. As a result, people have been negatively affected by the drug and are looking for compensation for their injuries.

Xeljanz

If you or a loved one has been injured or has died from a serious side effect related to Xeljanz, you may want to file a Xeljanz lawsuit. You can get monetary compensation for medical bills, pain and suffering, lost wages, and more. In addition, a wrongful death case can bring additional damages, including funeral costs and loss of love and companionship.

Many Xeljanz lawsuits allege that Pfizer failed to warn patients of the risks associated with the drug. As a result, the drug company has been facing increasing numbers of Xeljanz lawsuits. It is vital that pharmaceutical companies research their drugs properly before marketing them to the public, so that they can warn consumers and doctors about potential risks and side effects.

Xeljanz side effects

A Xeljanz side effects lawsuit can be a beneficial way to receive compensation for injuries that you suffered from this medication. This lawsuit is new and may take several years to settle, and the amount of compensation will depend on the severity of your injuries. As with any lawsuit involving a dangerous drug, it is important to submit as much information as possible about your injury. The more detail you can provide about your condition, the higher your settlement will be. To find out more about the process, consider speaking with a dangerous drugs attorney.

Pfizer was required by the FDA to add a black box warning on the label of Xeljanz, which warned that this drug increased the risk of blood clots and cardiovascular events. It also warned that patients who take 10mg twice a day should limit their use of the medication to second-line therapy.

Xeljanz cancer risk

The Xeljanz cancer risk lawsuit claims that the drug caused severe heart damage, blood clots, and cancer in patients. Although not yet consolidated into a class action lawsuit, individual lawsuits filed against Pfizer are moving forward one at a time through the legal system. If you have been a victim of this drug’s dangerous effects, contact Simmons and Fletcher, P.C. for a free consultation.

The drug was introduced on the market in 2007, and the FDA recently issued a safety alert regarding the drug’s risk of blood clots and pulmonary embolism. The drug also has a high risk of developing heart problems and cancer, and it should be used only as second-line therapy.

Xeljanz heart problems

Although the FDA approved Xeljanz in 2012, it has now been linked to heart problems in patients. Experts in the field are concerned that Xeljanz causes heart problems, which can result in serious conditions, such as pulmonary embolism and blood clots. As a result, the FDA ordered Pfizer to conduct a post-marketing study, A3921133, to evaluate the drug’s risk of cardiovascular events. This study found that Xeljanz patients were at a 30% higher risk of developing heart problems than those who did not take the drug.

Xeljanz users have also been reported to suffer from pulmonary embolism and deep vein thrombosis, which are life-threatening complications that can affect the heart and other vital organs. These types of problems have caused a number of deaths and have been linked to the drug.

Xeljanz pulmonary embolism

If you have suffered from a pulmonary embolism, a stroke, or any other blood clot-related injury, you may be able to file a Xeljanz lawsuit against the drug maker. Depending on the severity of your injury, you may be able to receive significant financial compensation.

Although the FDA has approved the drug, warnings about the risk of pulmonary embolism have been available since July 2019. Many people are now filing Xeljanz pulmonary embalism lawsuits after suffering serious complications due to the blood clot. While Xeljanz is a highly effective anti-inflammatory drug, it has been linked to a number of side effects, including cancer and heart problems.

Xeljanz deep-vein thrombosis

The Xeljanz deep-veine thrombosis lawsuit is a growing civil action in which injured patients are seeking compensation. These lawsuits can include both punitive damages and class action status. The amount of compensation will be based on the amount of damage suffered by the plaintiff, as well as past or future medical expenses and lost income. A qualified attorney can help you assess your claims and file a lawsuit.

The drug has been linked to a number of health problems, including pulmonary embolism and pulmonary vein thrombosis. A blood clot can lodge in a vein or artery in the lungs, and the symptoms include chest pain, shortness of breath, increased sweating, and bluish-coloured skin. Moreover, several clinical trials have shown that Xeljanz patients are at an increased risk of heart problems, including heart attacks.